169303 ⎘
Investigating or analysing materials by specific methods not covered by groups -; Biological material, e.g. blood, urine ; Haemocytometers; Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
Methods and systems for performing single cell analysis of molecules and molecular complexes
#902Modified multispanning membrane polypeptides and methods of use thereof to screen therapeutic agents
#903TFPI inhibitors and methods of use
#904Methods for categorizing and treating subjects at risk for pulmonary exacerbation and disease progression
#905Anti-SIRPa antibodies and their therapeutic applications
#906GALECTIN IMMUNOTHERAPY
#907Neurokinin antagonists and uses thereof
#908NANOBIOSENSOR FOR DETECTING ALLERGIES, MANUFACTURING METHOD THEREFOR, AND DETECTION SYSTEM COMPRISING SAME
#909Device for additive delivery of reagents and related methods and systems
#910Biomarkers for diagnosing post traumatic stress disorder
#911PHARMACOKINETIC ANIMAL MODEL
#912Biosensors for chloride ions
#913Polypeptides and polypeptide constructs comprising single domain antibodies directed against von willebrand factor
#914ANTIBODY AGAINST PEPTIDE ENCODED BY EXON-21 OF PERIOSTIN AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING INFLAMMATION-ASSOCIATED DISEASES CONTAINING THE SAME
#915Anti-polyubiquitin antibodies and methods of use
#916BIOMARKERS
#917MEMBRANE TRANSPORTER ASSAY AND METHODS OF USE
#918Prediction of hepatocellular carcinoma onset after clearance of hepatitis C virus
#919BH4 stabilized peptides and uses thereof
#920Method of testing for pulmonary hypertension
#921Apparatus for disease detection
#922Apparatus for disease detection
#923Polyspecificity reagents, methods for their preparation and use
#924Antigen array
#925Mannitol-based amphipathic compound and use thereof
#926Medical use of CREG protein
#927METHOD FOR EARLY DIAGNOSING AND TREATING ACUTE CORONARY SYNDROME
#928Methods of identifying a polypeptide target for degradation by a modulator of CRBN
#929Antibody binding to HEG1 and use of the antibody for detection and treatment of mesothelioma
#930Methods of treating volume depletion and kidney injury
#931Method to evaluate the stability of a protein-based formulation
#932Reaction container and biochemical analysis method
#933Read Through Of Truncated Proteins In Premature Termination Codon Diseases Using An Optimized Genetic Codon Expansion System
#934CD131 binding proteins
#935Compound for specifically binding to amyloid β-protein
#936USES AND METHODS FOR MODULATING BILE ACID HOMEOSTASIS AND TREATMENT OF BILE ACID DISORDERS AND DISEASES
#937Modelling system
#938ASSAYS FOR B-TYPE NATRIURETIC PEPTIDE ANALOGUES RESISTANT TO PROLYL-SPECIFIC DIPEPTIDYL DEGRADATION
#939DEVICES, SYSTEMS AND METHODS FOR SAMPLE DETECTION
#940Modelling system
#941Protein binding domains stabilizing functional conformational states of GPCRs and uses thereof
#942SYSTEMS, APPARATUSES, AND METHODS FOR ASSESSMENT OF LONG TERM STABILITY OF SAMPLES
#943Device with integrated methods for reverse transcription polymerase chain reaction (RT-PCR) and/or DNA/protein array based analyses
#944IRS MODULATORS
#945PROTEIN BINDING DOMAINS STABILIZING FUNCTIONAL CONFORMATIONAL STATES OF GPCRS AND USES THEREOF
#946Methods for determining molecule folding associated with proteopathies
#947Stabilized peptoid-peptide hybrids and uses thereof
#948Adenovirus-associated viral vectors for expressing variants of tetratricopeptide repeat (TPR)-containing Rab8b interacting (TRIP8b) protein in neurons and uses thereof for treating major depressive disorder (MDD)
#949Apparatus and method for generating three-dimensional image of polymer solute substance which exists in liquid solvent
#950Process for in vitro diagnosis of hepatic disorders
#951Binding domain mapping
#952METHOD FOR USING BIOLOGICAL MATERIAL FOR DETERMINATION OF DIFFERENCES IN BINDING TO A MOLECULE OF INTEREST
#953Antibody molecules to CD73 and uses thereof
#954Method for detecting test substance
#955Mobilization of pluripotent stem cells for ischemic cerebral infarction
#956Bio-sensor having interdigitated microelectrode using response of receptor and target bioproducts
#957Methods and compositions for targeting polyubiquitin
#958Multiplexed assays
#959RECOMBINANT PICP PROTEIN, AND METHOD FOR PREPARING ANTIBODY SPECIFICALLY BINDING THERETO
#960Composition for inhibiting angiogenesis comprising nanoparticle-vitreous body-based protein complex as active ingredient, and use thereof
#961Isolation And Use Of Pluripotent Stem Cell Population From Adult Neural Crest-Derived Tissues
#962Wearable digital device for personal health use for saliva, urine and blood testing and mobile wrist watch powered by user body
#963Methods of screening
#964Detection of cerebrospinal fluid
#965SEMAPHORIN 3A FOR TREATMENT AND PROGNOSIS OF SYSTEMIC LUPUS ERYTHEMATOSUS
#966Genetically encoded biosensors
#967Method for designing compounds and compositions useful for targeting high stoichiometric complexes to treat conditions, including treatment of viruses, bacteria, and cancers having acquired drug resistance
#968AROMATIC-CATIONIC PEPTIDES AND USES OF SAME
#969THE EXOCYST AS A NOVEL DRUG TARGET OF ENDOSIDIN2 AND APPLICATION AS A THERAPEUTIC
#970Humanized anti-CLL-1 antibodies
#971Compositions for detection, inhibition and imaging of indoleamine 2, 3-dioxygenase 1 (IDO1) and methods of making and using same
#972Expression cassette and host cell for expressing a Vip3-interacting protein
#973Streptavidin muteins and methods of using them
#974Lactone-based probes and methods of use thereof
#975MIC-1 compounds and uses thereof
#976Cyclin-dependent kinase substrate
#977Systems, Methods and Computer Readable Storage Media for Analyzing a Sample
#978Automated sample quality assessment
#979Anti-nodal antibodies and methods of using same
#980NON-SURGICAL METHOD OF TREATMENT FOR CATARACT
#981Systems and methods using nuclear magnetic resonance (NMR) spectroscopy to evaluate pain and degenerative properties of tissue
#982BLOOD TEST TO PREDICT ENDURANCE ATHLETIC PERFORMANCE
#983Compositions and methods for protein detection
#984STABILIZED BIOACTIVE PEPTIDES AND METHODS OF IDENTIFICATION, SYNTHESIS, AND USE
#985Process and kit for determining in vitro the immune status of an individual
#986Therapeutic and diagnostics compositions targeting toll-like receptors and methods thereof
#987Method for the in vitro diagnosis of thyroid diseases
#988Biomarkers and methods of diagnosing and prognosing mild traumatic brain injuries
#989Combination comprising an aminothiolester compound or a pharmaceutically acceptable salt thereof and a compound able to increase the H2O2 level in cancer cells of a subject
#990Accurate measurement of glutathione for disease diagnosis and drug metabolite screening
#991Systems and methods for determining a chemical state
#992Anti-nodal antibodies and methods of using same
#993Compound for specifically binding to amyloid β-protein
#994Methods of treating a subject having heart failure that include detecting levels of galectin-3 and soluble ST2
#995Nanovesicles, methods, and systems for diagnosis and prognosis of cancer
#996SEPARATION METHOD, DETECTION METHOD, SIGNAL MEASUREMENT METHOD, DISEASE DETERMINATION METHOD, DRUG EFFICACY ASSESSMENT METHOD, KIT, LIQUID COMPOSITION, AND SPECIMEN DILUENT
#997Method of quantifying peptide-derivative libraries using phage display
#998Mutant proteins and methods for their production
#999Methods for predicting and treating patients with increased risk of adverse pregnancy outcome
#1000Manufacturing device and manufacturing method of test strip
#1001Method for detecting molecular interactions using an immobilized nucleic acid
#1002Xylene-based amphiphilic compound and use thereof
#1003Method of Identifying Transmembrane Protein-interacting Compounds
#1004Proteins targeting orthologs
#1005METHODS FOR DEVELOPING PERSONALIZED DRUG TREATMENT PLANS AND TARGETED DRUG DEVELOPMENT BASED ON PROTEOMIC PROFILES
#1006INFLAMMATION-ENABLING POLYPEPTIDES AND USES THEREOF
#1007Immunogenic antigen identification from a pathogen and correlation to clinical efficacy
#1008SOLUBLE NEEDLE ARRAYS FOR DELIVERY OF INFLUENZA VACCINES
#1009Non?invasive prediction of risk for sudden cardiac death
#1010Method for predicting the risk of obesity in a subject
#1011A COMPOSITION COMPRISING PROSTACYCLIN ANDOR ANALOGUES THEREOF FOR TREATMENT OF ACUTE CRITICALLY ILL PATIENTS
#1012Scaffold proteins derived from plant cystatins
#1013Microfluidic Platform For Rapid Biologics Analysis
#1014Multiplex biomarker for use in evaluation of state of accumulation of amyloid B in brain, and analysis method for said evaluation
#1015Method for evaluating the possibility of suffering from pancreatic disease
#1016Method and kit for detecting glutathione
#1017INDIVIDUAL METHOD PREDICTIVE OF THE DNA-BREAKING GENOTOXIC EFFECTS OF CHEMICAL OR BIOCHEMICAL AGENTS
#1018PREDICTIVE METHOD FOR CHARACTERIZING THE SENSITIVITY OF A TUMOUR IN RESPONSE TO A DNA-BREAKING TREATMENT
#1019Systems and methods for proteomic activity analysis using DNA-encoded probes
#1020IGFBP7 for prediction of risk of AKI when measured prior to surgery
#1021KITS, COMPOSITIONS AND METHODS FOR DETECTING A BIOLOGICAL CONDITION
#1022Humanized anti-DKK2 antibody and uses thereof
#1023Biorecognition elements for rapid detection of biocontamination
#1024Multiplexed Analyses of Test Samples
#1025Use of human small leucine zipper protein in osteogenesis procedure
#1026Compositions and methods relating to galectin detection
#1027Blood volume analysis with volume-aware blood component measures and treatment
#1028Biomarkers and methods for assessing psoriatic arthritis disease activity
#1029TEAD transcription factor autopalmitoylation inhibitors
#1030Methods and reagents for diagnosing Sjögren's Syndrome
#1031Genetically encoded biosensors
#1032DRUG DISCOVERY AND PROTEIN-PROTEIN INTERACTION ASSAY USING FLUORESCENT PROTEIN EXCHANGE
#1033METHOD FOR DIAGNOSING EARLY ONSET OF ALZHEIMER'S DISEASE OR MILD COGNITIVE IMPAIRMENT
#1034LOW FIELD XENON CAGE RELAXOMETRY
#1035Soluble and stable heterodimeric TCR
#1036Methods of using antibodies to determine periostin levels in a sample
#1037Methods and Compositions for Highly Sensitive Detection of Molecules
#1038SRM/MRM assays for cancer
#1039Antibody-mediated neutralization of Ebola viruses
#1040Bioparticle characterization and identification using interface thermal resistance measurement during bioparticle adhesion and detachment
#1041Degron fusion constructs and methods for controlling protein production
#1042NOVEL ASSAY TO DETECT HUMAN PERIOSTIN
#1043Modified H7 Hemagglutinin Glycoprotein of the Influenza A/Shanghai/2/2013 H7 Sequence
#1044Immunogenic compositions comprising polypeptides and fusions thereof
#1045Nanoscale biochemical sample preparation and analysis
#1046GPC3-targeting therapeutic agent which is administered to patient for whom the GPC3-targeting therapeutic agent is effective
#1047POLYPEPTIDE SPECIFICALLY BINDING TO CD34 MOLECULE AND USE THEREOF
#1048Inflammasome activation in myelodysplastic syndromes
#1049CD8a-binding fibronectin type III domains
#1050Stabilized minimal coiled-coil mimetics
#1051Mobility Electrophoresis Separation Device, Operating Method Thereof, and Interface Between Liquid Chromatography and Mass Spectrometry
#1052Use of molecular marker Dkk-3 associated with muscle atrophy
#1053CANCER IMMUNOTHERAPEUTIC
#1054Diagnosis and treatment of MERS-related renal disease
#1055Biochip and method for manufacturing biochip
#1056Device and method for detecting creatinine and albumin to creatinine ratio
#1057Blood-based biomarkers of tumor sensitivity to PD-1 antagonists
#1058BTN3A ECTODOMAIN PROTEINS AND METHODS OF USE
#1059TOLL-LIKE RECEPTOR 2 BINDING EPITOPE AND BINDING MEMBER THERETO
#1060Method for clinically and pathologically monitoring Alzheimer's disease through concentration of amyloidbeta in plasma
#1061Secreted Protein Acidic and Rich in Cysteine (SPARC) Protein SRM/MRM Assay
#1062Evaluation of Cas9 molecule/guide RNA molecule complexes
#1063Antibacterial polypeptide libraries and methods for screening the same
#1064Methods and systems for measuring plasma renin activity
#1065PROTEOGENOMIC ANALYSIS SYSTEM AND METHODS
#1066METHOD FOR IDENTIFYING COMPOUNDS THAT MODULATE A T2R TASTE RECEPTOR
#1067Compositions and methods for allergen detection
#1068Treatment with methylation-controlled J protein (MCJ)
#1069Serum biomarker panels for bipolar disorder
#1070Method for estimating number of podocytes in urine
#1071Biosensor tattoos and uses therefor for biomarker monitoring
#1072Bio-sensing device
#1073Method for screening for sunlight protection functional material and method for evaluating sunlight protection effect
#1074Methods and systems for predicting colorectal cancer incidence and mortality
#1075METHOD FOR MEASURING GLYCOPROTEIN, METHOD FOR EXAMINING LIVER DISEASE, REAGENT FOR QUANTITATIVE DETERMINATION OF GLYCOPROTEIN, AND GLYCAN-MARKER GLYCOPROTEIN AS AN INDEX FOR CLINICAL CONDITIONS OF LIVER DISEASE
#1076Polypeptides, peptides, and proteins functionalized by alkylation of thioether groups via ring-opening reactions
#1077Systems and methods for predicting glycosylation on proteins
#1078Highly Sensitive System and Methods for Analysis of Troponin
#1079Insect inhibitory proteins
#1080leukocidins, therapeutic compositions, and uses thereof
#1081METHODS, COMPOSITIONS, AND KITS INVOLVING ALTERATION OF THE CHAPERONE PROTEIN AXIS IN A SUBJECT
#1082System and method for identification of a synthetic classifier
#1083METHOD FOR PREDICTING AND EVALUATING RESPONSIVENESS TO CANCER TREATMENT WITH DNA-DAMAGING CHEMOTHERAPEUTIC AGENTS
#1084COMPOSITIONS AND METHODS FOR ENHANCED FLUORESCENCE
#1085Methods and kits for determining von willebrand factor activity in the absence of ristocetin
#1086Composition comprising prostacyclin andor analogues thereof for treatment of acute critically ill patients
#1087Detection method for quaternary ammonium compound having γ-carboxyl group
#1088EX VIVO PLASMA ENZYME ACTIVITY ASSAY USING INHIBITORS AS A NEGATIVE CONTROL
#1089Materials and methods for diagnosis and treatment of Alzheimer's disease
#1090Biomarkers for diagnosis and prognosis of corneal ectatic disorders
#1091Model gut system
#1092Method for detecting monoclonal antibody using mass spectrometry
#1093MZB1, a novel B cell factor, and uses thereof
#1094Super-resolution fluorescent imaging probe
#1095Methods for second harmonic generation imaging of protein crystals
#1096Development and use of cysteine-labeled fluorescent probes of unbound analytes
#1097ASSAY PANELS
#1098Chiral analysis method of bound amino acid and chiral analysis system
#1099Methods for diagnosing and reducing incidences of cardiac allograft rejection
#1100Monitoring of neuromodulation using biomarkers
#1101Methods and compositions for treating and/or preventing a disease or disorder associated with abnormal level and/or activity of the IFP35 family of proteins
#1102Device for pretreatment of sample and analyzer equipped therewith, and method for pretreatment of sample
#1103Methods of treatment using an interferon gamma inhibitor
#1104Nano-pore arrays for bio-medical, environmental, and industrial sorting, filtering, monitoring, or dispensing
#1105Genetically encoded biosensors
#1106Methods for early identification of bone healing ability in injured patients
#1107METHOD OF ANALYZING GLYCATED PROTEIN, ANALYSIS REAGENT, ANALYSIS KIT, AND TEST PIECE FOR ANALYSIS
#1108Method of identifying and treating a person having a predisposition to or afflicted with a cardiometabolic disease
#1109ISOLATION OF ADULT MULTIPOTENTIAL CELLS BY TISSUE NON-SPECIFIC ALKALINE PHOSPHATASE
#1110Composition and system for separating and detecting alpha-fetoprotein variant and use thereof
#1111Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of phenylalanyl-beta-tRNA synthetases
#1112PROGNOSIS OF ADVERSE EVENTS IN PATIENTS WITH SUSPECTED CHRONIC HEART FAILURE
#1113Systems and Methods for Detecting a Biological Condition
#1114Quantum capacitance sensing
#1115Anti-active GIP antibody
#1116Methods for protein and peptide reduction
#1117GPC3 EPITOPE PEPTIDES FOR TH1 CELLS AND VACCINES CONTAINING THE SAME
#1118Methods for modular synthesis of N-glycans and arrays thereof
#1119Methods and kits for detecting misfolded proteins
#1120HPV-related fusion protein and applications thereof
#1121Drug efficacy test method for dementias utilizing astrocyte-derived exosomes
#1122Method for determining state of differentiation of stem cells, and novel differentiation marker used therefor
#1123Markers for the Diagnosis of Celiac Disease
#1124Method of Identifying Transmembrane Protein-interacting Compounds
#1125Detection of human umbilical cord tissue-derived cells
#1126GLYCOPOLYMER CAPTURE MATRIX FOR USE WITH SURFACE-ENHANCED RAMAN SPECTROSCOPY DETECTION AND RELATED SYSTEMS AND METHODS
#1127Method for assessing therapeutic effect of anti-cancer agent having anti-CD4 antibody as active ingredient
#1128Vedolizumab for the Treatment of Fistulizing Crohn's Disease
#1129Anti-TNF-α fully human monoclonal antibodies with low immunogenicity and application thereof
#1130Insecticidal proteins and methods for their use
#1131METHOD, KIT AND TEST STRIP FOR DETECTING KAWASAKI DISEASE
#1132Compositions and methods for treating eye infections and disease
#1133PREDICTION MARKER
#1134Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of histidyl-tRNA synthetases
#1135CD8-SPECIFIC CAPTURE AGENTS, COMPOSITIONS, AND METHODS OF USING AND MAKING
#1136METHOD OF DIAGNOSING AND TREATING BRAIN ENDOTHELIAL INFLAMMATION RELATED DISEASE
#1137Neukinase, a downstream protein of neuregulin
#1138BIOMARKER FOR DETERMINING MITOCHONDRIAL DAMAGE IN FRIEDREICH'S ATAXIA
#1139Method of analyzing the content of drops and associated apparatus
#1140METHODS FOR DISCOVERING THERAPEUTICS THAT ALTER THE STABILITY OF TARGET PROTEINS
#1141NOVEL TGF-ALPHA MUTANT PROTEINS
#1142PEPTIDE COMPOSITION AND USES THEREOF
#1143Treatment of cancer and inhibition of metastasis using hemoglobin beta subunit
#1144BIOLOGICALLY ACTIVE PEPTIDOMIMETIC MACROCYCLES
#1145Method and composition for a protein transduction technology and its applications
#1146Mass spectrometry for determining if a mutated variant of a target protein is present in a sample
#1147QUINOLINES AND THEIR USE FOR TREATING ENDOPLASMIC RETICULUM STRESS-CAUSED DISEASES
#1148DETECTION AND MEASUREMENT OF GRASS POLLEN PROTEINS
#1149RECEPTOR LINKED REGENERATED CELLULOSE MEMBRANE AND METHODS FOR PRODUCING AND USING THE SAME
#1150EVAPORATION ON SUPERHYDROPHOBIC SURFACES FOR DETECTION OF ANALYTES IN BODILY FLUIDS
#1151Cancer treatment and immune system regulation through FAT10 pathway inhibition
#1152Detecting residual host cell proteins in recombinant protein preparations
#1153ANALOGS OF SHK TOXIN AND THEIR USES IN SELECTIVE INHIBITION OF KV1. 3 POTASSIUM CHANNELS
#1154Detecting protein-protein interactions
#1155CARBON NANOTUBE COMPOSITE, SEMICONDUCTOR DEVICE AND METHOD FOR PRODUCING THE SAME, AND SENSOR USING THE SAME (AS AMENDED)
#1156Aptamers for purifying and quantifying gelsolin and its variants
#1157Methods for establishing a vedolizumab dosing regimen to treat patients with irritable bowel disease
#1158BIOMIMETIC POLYMERS FOR THE PREVENTION AND TREATMENT OF VIRAL DISEASES
#1159Biomaterials for neuronal implants and use of said biomaterials in the diagnosis and therapy of neuronal diseases
#1160Methods for analysis of protamine
#1161Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of phenylalanyl-alpha-tRNA synthetases
#1162EXTRACELLULAR MATRIX METALLOPROTEINASE INDUCER (EMMPRIN) PEPTIDES AND BINDING ANTIBODIES
#1163Isolated mucins and different microorganisms, and methods of use
#1164Isolating Cells Expressing Secreted Proteins
#1165Pig model for diabetes
#1166Increased alpha-prime beta-conglycinin soybeans
#1167Ligand-directed covalent modification of protein
#1168α- and γ-truxillic acid derivatives and pharmaceutical compositions thereof
#1169PEPTIDOMIMETIC MACROCYCLES WITH IMPROVED PROPERTIES
#1170CARBOHYDRATE FUNCTIONALIZED CATANIONIC SURFACTANT VESICLES FOR DRUG DELIVERY
#1171IMPROVED FACTOR VIII PREPARATIONS SUITABLE FOR THERAPEUTIC USE AND PROCESSES TO OBTAIN THESE
#1172Method for detecting cardiac failure patient
#1173Biomarker sampling in the context of neuromodulation devices, systems, and methods
#1174Feline bitter taste receptors and methods
#1175Analysis method of molecular interactions on protein nanoparticles using flow cytometry
#1176Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of Valyl-tRNA synthetases
#1177Compositions and methods for treating eye infections and disease
#1178Stabilized peptoid-peptide hybrids and uses thereof
#1179MICROFLUIDIC DEVICES FOR THE RAPID DETECTION OF ANALYTES
#1180Compstatin analogs with improved potency and pharmacokinetic properties
#1181Polymer based signal amplification for protein and cell detection
#1182APPARATUS AND METHOD FOR ESTIMATING CHANGES TO HUMAN HEALTH BASED ON MONITORING HAIR PARAMETERS
#1183Method for the diagnosis of or risk for a disease mediated via the alternative pathway of the complement system
#1184Protein melt analysis using dipyrrometheneboron difluoride compounds
#1185MODEL GUT SYSTEM
#1186COMPOSITION OF ALLERGEN EXTRACTS HAVING REDUCED TOXICITY AND METHOD OF PRODUCTION THEREOF
#1187TFPI inhibitors and methods of use
#1188GALECTIN IMMUNOTHERAPY
#1189Fusion Protein Suitable for Measurement of Autophagy, Nucleic Acid Encoding Said Fusion Protein, and Use of These
#1190Assays for B-type natriuretic peptide analogues resistant to prolyl-specific dipeptidyl degradation
#1191Insect inhibitory proteins
#1192Antibody purification and purity monitoring
#1193Fibronectin binding domains with reduced immunogenicity
#1194Epitope tag and method for detection and/or purification of tagged polypeptides
#1195Antibody, epitope tag and method for detection, capture and/or purification of tagged polypeptides
#1196Devices and associated methods for monitoring of neuromodulation using biomarkers
#1197METHOD OF DETERMINING PANCREATIC DISEASE
#1198Use of acetylated tubulin as a biomarker of drug response to furazanobenzimidazoles
#1199Soluble needle arrays for delivery of influenza vaccines
#1200HIGHLY CONCENTRATED DRUG PARTICLES, FORMULATIONS, SUSPENSIONS AND USES THEREOF